Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cytokinetics (CYTK) Restructuring Costs: 2009-2012

Historic Restructuring Costs for Cytokinetics (CYTK) over the last 4 years, with Dec 2012 value amounting to -$56,000.

  • Cytokinetics' Restructuring Costs rose 179400.00% to $3.6 million in Q3 2013 from the same period last year, while for Sep 2013 it was $7.2 million, marking a year-over-year increase of 99.58%. This contributed to the annual value of -$56,000 for FY2012, which is 104.70% down from last year.
  • As of FY2012, Cytokinetics' Restructuring Costs stood at -$56,000, which was down 104.70% from $1.2 million recorded in FY2011.
  • In the past 5 years, Cytokinetics' Restructuring Costs ranged from a high of $3.8 million in FY2010 and a low of -$56,000 during FY2012.
  • In the last 3 years, Cytokinetics' Restructuring Costs had a median value of $1.2 million in 2011 and averaged $1.6 million.
  • Its Restructuring Costs has fluctuated over the past 5 years, first skyrocketed by 10,613.85% in 2010, then slumped by 104.70% in 2012.
  • Yearly analysis of 4 years shows Cytokinetics' Restructuring Costs stood at -$36,030 in 2009, then skyrocketed by 10,613.85% to $3.8 million in 2010, then crashed by 68.53% to $1.2 million in 2011, then plummeted by 104.70% to -$56,000 in 2012.